Our hospital-university partnerships drive our success. University Hospitals of Leicester NHS Trust is one of the largest acute research and teaching hospitals in the country. The University of Leicester is ranked second in the country for clinical medicine in the 2021 Research Excellence Framework. Loughborough University is in the top 20 for research-led universities in the country.
In this funding round of the BRC we are joined by the University Hospitals of Northamptonshire NHS Group, meaning we can bring more clinicians and scientists together, and give opportunities for even more patients to take part in and shape our research.
As well as our extensive NIHR infrastructure, we work with a range of local, regional and national partners and stakeholders to increase the scope and impact of our work:
Leicestershire Academic Health Partners (LAHP)
A collaboration between the University Hospitals of Leicester NHS Trust, Leicestershire Partnership NHS Trust and the University of Leicester, LAHP combines the clinical and academic excellence of its partners to accelerate the transmission of cutting-edge research into healthcare innovations to improve the health and well-being of the people of Leicester, Leicestershire and Rutland (LLR).
Centre for Ethnic Health Research
The Centre for Ethnic Health Research (CEHR) has one clear vision, which is “to reduce ethnic health inequalities” by supporting individuals and organisations to involve and understand the needs of ethnic minority and underserved communities when planning and undertaking research and healthcare delivery.
Leicester Clinical Trials Unit (CTU)
Leicester Clinical Trials Unit (LCTU) is a fully-registered UK Clinical Research Collaboration (UKCRC) trials unit working with investigators and clinicians to design and deliver high quality clinical research in partnership with major funding bodies, such as the NIHR, Cancer Research UK and British Heart Foundation.
Leicester, Leicestershire and Rutland (LLR) Integrated Care Board (ICB)
The NHS LLR ICB aims to deliver a health and care system that tackles inequalities in health and improves the health, wellbeing and life experiences of the local population. It does this by setting the strategic direction of the whole health system, and arranges and manages the budget for the NHS in LLR. The ICB is formed of senior leaders from NHS organisations and local authorities in the area.
East Midlands Academic Health Sciences Network (EMAHSN)
EMAHSN brings together partners from across all sectors involved in health and care – including the NHS, social care and public health, patients, research, third sector and industry – to identify, test and spread new technologies and better ways of working. The aim is to save the NHS money, generate economic growth, empower health and care staff, and improve the experience and outcomes of patients.
Midlands Innovation Health
The aim of Midlands Innovation (MI) Health is to position the cutting-edge Medical and Health-based innovations and research produced across the Midlands at the forefront of the UK.
Vascular Voice Network
The Vascular Voice Network is a voluntary advisory group bringing together representatives from charities and umbrella organisations focused on both common and rare vascular conditions.
Its purpose is to create a collaborative space for networking, learning, and sharing insights across the vascular landscape. By working together on research, awareness, and policy initiatives, it aims to strengthen a national voice that champions conditions with shared symptoms and drives progress toward better understanding, care, and treatments.
The NIHR Diet and Activity Research Translation (DART) Collaboration
The NIHR Diet and Activity Research Translation (DART) Collaboration brings together experts in health behaviours.
It specialises in diet and nutrition, sleep, sedentary behaviour and physical activity, lifecourse and ageing, obesity and weight management. These behaviours are important because they impact all the major long-term conditions challenging people and the NHS, including cancers, heart disease and type 2 diabetes.